Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Page :A5

    
• • ·Table of Contents

    Page :A8

    
• • ·Information for Readers

    Page :A32

    
• • ·JAAD Case Reports Article List

    Page :A41

    
• • ·Journal Based CME Instructions and Information

    Page :A52

    

• Continuing Medical Education

  • ·Melanoma in skin of color: Part I. Epidemiology and clinical presentation

    Page :445-456

    Elise K. Brunsgaard, Yelena P. Wu, Douglas Grossman

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :457

    
  • ·Answers to CME examination

    Page :458

    
  • ·Melanoma in skin of color: Part II. Racial disparities, role of UV, and interventions for earlier detection

    Page :459-468

    Elise K. Brunsgaard, Jakob Jensen, Douglas Grossman

    Résumé Résumé Plan Plan
  • ·CME examination

    Page :469

    
  • ·Answers to CME examination

    Page :470

    

• Letter from the Journal

  • ·Letter from the journal: Improving diagnostic acumen and patient outcomes

    Page :471-472

    Dirk M. Elston, Jane M. Grant-Kels, Nikki A. Levin, Murad Alam, Robert T. Brodell, Anthony P. Fernandez, Alexandra Flamm, M. Yadira Hurley, Desiree Ratner, Julie V. Schaffer, Klint Peebles, Andrew F. Alexis, Alaina J. James

    

• This Month in JAAD

  • ·This Month in JAAD: September 2023

    Page :473

    Dirk M. Elston

    

• This Month in JAAD Case Reports

  • ·This month in JAAD Case Reports: September 2023 Images in Dermatology Quizzes

    Page :474

    Brett Sloan

    

• This Month in JAAD International

  • ·This Month in JAAD International: September 2023: Hydrochlorothiazide and skin cancer in Japan

    Page :475

    Jonathan Kantor

    

• A Clinician's Perspective

  • ·Gaining perspective on messenger RNA coronavirus disease 2019 vaccination risk

    Page :476-477

    Warren R. Heymann

    

• Original Articles

  • ·Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)

    Page :478-485

    Andrew Blauvelt, Barry Ladizinski, Vimal H. Prajapati, Vivian Laquer, Alison Fischer, Samantha Eisman, Xiaofei Hu, Tianshuang Wu, Brian M. Calimlim, Blair Kaplan, Yingyi Liu, Henrique D. Teixeira, John Liu, Kilian Eyerich

    Résumé Résumé Plan Plan  
  • ·Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial

    Page :486-495

    Bruce Strober, Carle Paul, Andrew Blauvelt, Diamant Thaçi, Luis Puig, Mark Lebwohl, Katy White, Veerle Vanvoorden, Delphine Deherder, Natalie Nunez Gomez, Kilian Eyerich

    Résumé Résumé Plan Plan  
  • ·Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study

    Page :496-503

    Mei-Ju Ko, Wan-Chuan Tsai, Ping-Hsiu Tsai, Le-Yin Hsu, Kuo-Liong Chien, Hon-Yen Wu

    Résumé Résumé Plan Plan  
  • ·Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study

    Page :504-510

    Julia L. Gao, Jessika Sanz, Nicholas Tan, Dana S. King, Anna M. Modest, Erica D. Dommasch

    Résumé Résumé Plan Plan
  • ·Host and primary tumor factors for the development of multiple cutaneous squamous cell carcinomas among a retrospective cohort in Rhode Island

    Page :511-518

    Isabelle Moseley, Fadwa Ahmed, Erica Lin, Rachel Lim, Megan Hoang, Navya Baranwal, Leslie Robinson-Bostom, Tiffany Libby, Oliver Wisco, Abrar Qureshi, Eunyoung Cho

    Résumé Résumé Plan Plan  
  • ·Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort

    Page :519-528

    Jonathan I. Silverberg, Brenda Simpson, Katrina Abuabara, Emma Guttman-Yassky, Brian Calimlim, Colleen Wegzyn, Whitney Krueger, Amy Gamelli, Breda Munoz, Rachel W. Faller, Julie M. Crawford, Ayman Grada, Lawrence F. Eichenfield, TARGET-DERM Investigators

    Résumé Résumé Plan Plan  
  • ·Asian American and Pacific Islander patients with melanoma have increased odds of treatment delays: A cross-sectional study

    Page :529-536

    Lauren S. Fane, Angela H. Wei, Raghav Tripathi, Jeremy S. Bordeaux

    Résumé Résumé Plan Plan  
  • ·RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study

    Page :537-543

    Ida M. Heerfordt, Peter A. Philipsen, Jeppe D. Andersen, Linnea Langhans, Grethe Schmidt, Niels Morling, Hans Christian Wulf

    Résumé Résumé Plan Plan  

• Dermatologic Surgery

  • ·Outcomes of invasive melanoma of the head and neck treated with Mohs micrographic surgery – A multicenter study

    Page :544-550

    Brandon T. Beal, Jeremy Udkoff, Leora Aizman, Jeremy Etzkorn, John A. Zitelli, Christopher J. Miller, Thuzar M. Shin, Joseph F. Sobanko, David G. Brodland

    Résumé Résumé Plan Plan  

• Clinical Reviews

  • ·Dermatologic manifestations and diagnostic assessments of the Ehlers-Danlos syndromes: A clinical review

    Page :551-559

    Brent J. Doolan, Mark Lavallee, Ingrid Hausser, F. Michael Pope, Suranjith L. Seneviratne, Ingrid M. Winship, Nigel P. Burrows

    Résumé Résumé Plan Plan  

• Reviews

  • ·Cutaneous interaction with visible light: What do we know?

    Page :560-568

    Leah Cohen, Merrick A. Brodsky, Raheel Zubair, Indermeet Kohli, Iltefat H. Hamzavi, Mona Sadeghpour

    Résumé Résumé Plan Plan  
  • ·Interpretation of genomic sequence variants in heritable skin diseases: A primer for clinicians

    Page :569-576

    Jouni Uitto, Amir Hossein Saeidian, Leila Youssefian, Hassan Vahidnezhad

    Résumé Résumé Plan Plan  

• Research Letters

  • ·Lack of coverage for first-line treatments of pigmentary disorders in contrast to treatments of acne and rosacea: A survey of public and private insurers in California

    Page :577-579

    Mekaleya Tilahun, Jenna C. Lester

    
  • ·Correlation of clinician-reported outcomes with patient-reported outcomes by race and ethnicity in patients with atopic dermatitis

    Page :579-580

    Jourdan Hydol Smith, Jonathan I. Silverberg

    
  • ·Evaluating the landscape of discount and patient assistance programs for topical sunscreen products in the United States

    Page :580-582

    Stephanie Choi, Patrick Mulvaney

     
  • ·Epidemiology and diagnostic classification of adults presenting with an initial episode of leukocytoclastic vasculitis: A multicenter review of 440 patients

    Page :582-584

    Andrew C. Walls, Adam Faletsky, Brian Chu, Robert G. Micheletti, Arash Mostaghimi

     
  • ·A systematic review and critical appraisal of pharmacological treatments for pediatric hidradenitis suppurativa

    Page :584-586

    Ariana Moreno, Samuel C. Williams, Rie Goto, James G. Krueger, Yael Renert-Yuval

     
  • ·A cross-sectional study on skin cancer screening behaviors in sexual minorities among adults in the United States

    Page :586-589

    Katelyn J. Rypka, Audrey A. Jacobsen, Matthew Mansh

    
  • ·Diagnosis of perineural invasion during Mohs micrographic surgery guides clinical decision-making in the management of cutaneous squamous cell carcinoma

    Page :589-591

    Alexa B. Steuer, Maressa C. Criscito, Nicole Doudican, John A. Carucci, Mary L. Stevenson

    
  • ·Report of adverse events, 2021 to 2022, from the cutaneous procedures adverse events reporting (CAPER) registry

    Page :591-593

    Michael D. Yi, Ross Pearlman, Umer Nadir, Farhana Ikmal Hisham, Loma Dave, Kristin Hellquist, Murad Alam

    
  • ·Association of the dermatology chair’s gender with gender diversity of the program director and faculty

    Page :593-595

    Zaynah Awethe, Nassim Idouraine, Sonia Himed, Jessica Kaffenberger

     
  • ·Minimum thresholds deemed acceptable by patients and physicians for sensitivity and specificity of mobile skin cancer screening algorithms

    Page :595-597

    Noor Anvery, Bianca Kang, Rachel E. Christensen, McKenzie A. Dirr, Umer Nadir, Joaquin C. Brieva, M. Laurin Council, Jeffrey S. Dover, Timothy M. Kuzel, Kira Minkis, Bharat B. Mittal, Jeffrey D. Wayne, Simon S. Yoo, Murad Alam

    
  • ·Differences in thickness-specific incidence of cutaneous melanoma by county type in the United States, 2010 to 2019

    Page :597-600

    Daniel Y. Kim, Michael A. Marchetti, Rebecca I. Hartman

     
  • ·The impact of atopic dermatitis on alopecia areata: A 2-sample Mendelian randomization study

    Page :600-602

    Ross O’Hagan, Stella A. Caldas, Joel M. Correa da Rosa, Emma Guttman-Yassky, Benjamin Ungar

     
  • ·The utility of ChatGPT in generating patient-facing and clinical responses for melanoma

    Page :602-604

    Jade N. Young, Dina Poplausky, Melissa A. Levoska, Nicholas Gulati, Benjamin Ungar, Jonathan Ungar

    
  • ·Utilizing eye-tracking software to evaluate the efficacy of standardized total body skin examination

    Page :604-606

    Hannah H. Nam, Jacob Colello, Deep Patel, Alyson M. Rich, Katherine Hallock, Amy Longenecker, Jeffrey Miller, Ling Rothrock, Snehal Dhengre, Leesha Helm, Matthew Helm

      
  • ·Factors predicting response to oral methylprednisolone tapering treatment in alopecia areata: A retrospective study

    Page :606-608

    Hee Jeong Han, Han Seul Kim, Jin Cheol Kim, Jee Woong Choi

     
  • ·A retrospective case series: Unique clinical presentation and treatment outcomes of Trichophyton violaceum and soudanense tinea in a pediatric population

    Page :608-610

    Jenna K. Dick, Cynthia Nicholson, Ingrid Polcari, Christina Boull, Sheilagh M. Maguiness

    
  • ·Association between atopic dermatitis and cardiovascular disease in a nationally representative United States population

    Page :610-613

    Brandon Smith, Priya Engel, Sogol Stephanie Javadi, George Han, Jashin J. Wu

    
  • ·Patient views on race concordance and cultural mindfulness in dermatology: A cross-sectional study among people of color in the United States

    Page :613-614

    Kourtney Scott, Sneha Poondru, Kathryn L. Jackson, Roopal V. Kundu

    
  • ·Evaluation of skin of color publication trends over the past 2 decades in the Journal of the American Academy of Dermatology

    Page :614-616

    Britney N. Wilson, Rohan Shah, Claire Ufongene, Mary D. Sun, Andres Felipe Diaz, Dedee F. Murrell, Jenny E. Murase

     
  • ·Mortality in generalized pustular psoriasis: A population-based national register study

    Page :616-619

    Oskar Ericson, Sofia Löfvendahl, Jenny M. Norlin, Harald Gyllensvärd, Marcus Schmitt-Egenolf

     
  • ·A case-control pharmacovigilance study of TNF-alpha inhibitors and interleukin inhibitors on tuberculosis, Candida, lymphoma and suicidality using the FAERS database (2014-2020)

    Page :619-621

    Domenico Arcuri, Mohammed Kaouache, François Lagacé, Denis Sasseville, Ivan Litvinov

    
  • ·Online risk calculator and nomogram for predicting sentinel lymph node positivity in Merkel cell carcinoma

    Page :621-623

    Nolan J. Maloney, Sumaira Z. Aasi, Nour Kibbi, Kelsey E. Hirotsu, Lisa C. Zaba

     
  • ·“Shedding” low yield testing for telogen effluvium: A cross-sectional study of 16,381 laboratory results from newly diagnosed patients

    Page :623-626

    Rhiannon C. Miller, Sajjad Abedian, Shari R. Lipner

    

• Health Policy & Practice

  • ·Defining “Access to Care” for dermatology at academic medical institutions

    Page :627-628

    Bianca Patel, Travis W. Blalock

    
  • ·The Modernization of Cosmetics Regulation Act of 2022: What dermatologists need to know

    Page :629-631

    Aidan R. Filley, Carina M. Woodruff

    
  • ·The Congressional Skin Cancer Caucus: Characterizing the inaugural decade of activity, 2013-2022

    Page :632-634

    Aneesh Agarwal, Samir Kamat, Sumanth Chennareddy, George Hruza, Phillip M. Singer

     

• Commentary

  • ·Personalized photoprotection: Commentary on “Adjusting best practices in the treatment of melasma with a focus on patients with skin of color”

    Page :635-636

    Nayha P. Shetty, Susan C. Taylor, Henry W. Lim

    

• Ethics Journal Club

  • ·Ethics of encouraging a malpractice lawsuit against a dermatologist colleague

    Page :637-638

    Mehdi Farshchian, Vivian Liu, Jane M. Grant-Kels, Darius R. Mehregan

    

• Correction

  • ·Correction

    Page :639

    

• JAAD Online

  • ·A novel technique using lidocaine 2% topical gel for peristomal dermatitis

    Page :e111

    Brett C. Neill, Mary E. Favata, John A. Neill, Anand Rajpara, Daniel J. Aires

    Plan Plan  
  • ·Cryosnip for skin tag removal

    Page :e113

    Mehdi Farshchian, Arash Kimyai-Asadi, Steven Daveluy

    Plan Plan  
  • ·Improved postoperative bleeding control using the fanning pressure dressing technique

    Page :e115

    Cecilia Ardila, Isadore S. Tarantino, Leonard H. Goldberg, Kourosh Beroukhim, Arash Kimyai-Asadi

    Plan Plan   
  • ·Stick and move: Hemostasis for inpatient punch biopsies

    Page :e117

    Abraham H. Abdulhak, Cameron S. Nichols

    Plan Plan  
  • ·Staged excisions for extensive acne keloidalis

    Page :e119

    Paul Curtiss, Rajiv I. Nijhawan

    Plan Plan  
  • ·Autoclaved aluminum foil covering for smoke evacuators to maintain a sterile field

    Page :e121

    Kishan M. Shah, Divya Srivastava, Rajiv I. Nijhawan

    Plan Plan  
  • ·Use the dull side of a disposable curette

    Page :e123

    Dirk M. Elston

    Plan Plan  
  • ·An adapter window for precise skin marking during handheld reflectance confocal microscopic scanning

    Page :e125

    Rodrigo J. Schwartz, Genevieve Ho, Bruna Melhoranse Gouveia, Linda K. Martin, Pascale Guitera

    Plan Plan  
  • ·Experimenting with ChatGPT: Concerns for academic medicine

    Page :e127

    Rahim Hirani, Banu Farabi, Shoshana Marmon

    
  • ·Response to “Should we tell the readers what they should do?”

    Page :e131

    Beau Sitton, Abraham M. Korman

    
  • ·Vulval dermatologic diagnosis: Diagnosis by clinical presenting sign

    Page :e133

    Jane M. Grant-Kels

    
  • ·September 2023 iotaderma (#355)

    Page :e134

    Robert I. Rudolph